ArticleApplied microbiology and biotechnology2026
Reusability of immobilised lipase in the production of omega-3 oils from squid viscera.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Squid viscera, a waste product from squid processing, is a marine source of omega-3 fatty acid-rich oil suitable for nutritional supplement use. Squid visceral oil requires extraction and neutralisation of free fatty acids prior to consumption. Immobilised lipase (Lipozyme RMIM) is suitable for green neutralisation with high acylglyceride yields, high oxidative stability and retention of the antioxidant astaxanthin. Long-term utility of this method depends on lipase stability and reusability over multiple reaction cycles. To assess stability, this study monitored the performance of immobilised Lipozyme RMIM over 35 successive cycles of reuse in a custom-built one-litre reactor. This effectively reduces enzyme cost to 2.9% compared to single cycle use costs. We found a maximum of 97% free fatty acids in the crude oil were converted to acylglycerols under optimised reaction conditions in the first cycle, reducing to 86% after 35 reaction cycles. The partial loss of enzyme activity after each cycle appears to be a combination of enzyme unfolding and aggregation with a physical fracturing and breakdown of the resin, particularly after 30 cycles. KEY POINTS: • Immobilised Lipozyme RMIM neutralises squid oil effectively for 32 repeat cycles • Fatty acid composition of re-esterified squid oil is consistent over repeat cycles • Enzyme denaturation and carrier breakdown led to changes in lipase performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.